Literature DB >> 30009933

Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.

Valentina R Garbarino1, T Lee Gilman2, Lynette C Daws3, Georgianna G Gould4.   

Abstract

A variety of human and animal studies support the hypothesis that serotonin (5-hydroxytryptamine or 5-HT) system dysfunction is a contributing factor to the development of autism in some patients. However, many questions remain about how developmental manipulation of various components that influence 5-HT signaling (5-HT synthesis, transport, metabolism) persistently impair social behaviors. This review will summarize key aspects of central 5-HT function important for normal brain development, and review evidence implicating perinatal disruptions in 5-HT signaling in the pathophysiology of autism spectrum disorder. We discuss the importance, and relative dearth, of studies that explore the possible correlation to autism in the interactions between important intrinsic and extrinsic factors that may disrupt 5-HT homeostasis during development. In particular, we focus on exposure to 5-HT transport altering mechanisms such as selective serotonin-reuptake inhibitors or genetic polymorphisms in primary or auxiliary transporters of 5-HT, and how they relate to neurological stores of serotonin and its precursors. A deeper understanding of the many mechanisms by which 5-HT signaling can be disrupted, alone and in concert, may contribute to an improved understanding of the etiologies and heterogeneous nature of this disorder. We postulate that extreme bidirectional perturbations of these factors during development likely compound or synergize to facilitate enduring neurochemical changes resulting in insufficient or excessive 5-HT signaling, that could underlie the persistent behavioral characteristics of autism spectrum disorder.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autism spectrum disorder; Neurodevelopment; Selective serotonin reuptake inhibitors; Serotonin homeostasis; Serotonin transporter; Tryptophan

Mesh:

Substances:

Year:  2018        PMID: 30009933      PMCID: PMC6345621          DOI: 10.1016/j.phrs.2018.07.010

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  228 in total

Review 1.  The serotonin syndrome.

Authors:  Edward W Boyer; Michael Shannon
Journal:  N Engl J Med       Date:  2005-03-17       Impact factor: 91.245

2.  Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels.

Authors:  Ana M Coutinho; Inês Sousa; Madalena Martins; Catarina Correia; Teresa Morgadinho; Celeste Bento; Carla Marques; Assunção Ataíde; Teresa S Miguel; Jason H Moore; Guiomar Oliveira; Astrid M Vicente
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

Review 3.  The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of l-Tryptophan and l-Citrulline.

Authors:  Hellen A Oketch-Rabah; Amy L Roe; Bill J Gurley; James C Griffiths; Gabriel I Giancaspro
Journal:  J Nutr       Date:  2016-11-09       Impact factor: 4.798

Review 4.  Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders.

Authors:  Klaus-Peter Lesch; Jonas Waider
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

5.  MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders.

Authors:  Flora Tassone; Lihong Qi; Wenting Zhang; Robin L Hansen; Isaac N Pessah; Irva Hertz-Picciotto
Journal:  Autism Res       Date:  2011-04-29       Impact factor: 5.216

6.  Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects.

Authors:  P L Delgado; D S Charney; L H Price; H Landis; G R Heninger
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

7.  Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.

Authors:  George M Anderson; L Gutknecht; D J Cohen; S Brailly-Tabard; J H M Cohen; P Ferrari; P L Roubertoux; S Tordjman
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

8.  Ethnic differences in the serotonin transporter polymorphism (5-HTTLPR) in several European populations.

Authors:  Tatyana Noskova; Nela Pivac; Gordana Nedic; Anastasiya Kazantseva; Darya Gaysina; Gulnaz Faskhutdinova; Anna Gareeva; Zulfiya Khalilova; Elza Khusnutdinova; Dragica Kozaric Kovacic; Zrnka Kovacic; Mladen Jokic; Dorotea Muck Seler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-07-22       Impact factor: 5.067

9.  Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype.

Authors:  Christopher H van Dyck; Robert T Malison; Julie K Staley; Leslie K Jacobsen; John P Seibyl; Marc Laruelle; Ronald M Baldwin; Robert B Innis; Joel Gelernter
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

10.  The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring.

Authors:  J D A Olivier; H Akerud; H Kaihola; J L Pawluski; A Skalkidou; U Högberg; I Sundström-Poromaa
Journal:  Front Cell Neurosci       Date:  2013-05-21       Impact factor: 5.505

View more
  24 in total

1.  Serotonin disruption at gestation alters expression of genes associated with serotonin synthesis and reuptake at weaning.

Authors:  M C Fabio; I J C Servin-Bernal; A L Degano; R M Pautassi
Journal:  Psychopharmacology (Berl)       Date:  2022-09-05       Impact factor: 4.415

2.  Genetic Knockout of the Serotonin Reuptake Transporter Results in the Reduction of Dendritic Spines in In vitro Rat Cortical Neuronal Culture.

Authors:  Daniel Chaji; Varun S Venkatesh; Tomoaki Shirao; Darren J Day; Bart A Ellenbroek
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

3.  The role of 5-HTTLPR in autism spectrum disorder: New evidence and a meta-analysis of this polymorphism in Latin American population with psychiatric disorders.

Authors:  D L Nuñez-Rios; R Chaskel; A Lopez; L Galeano; M C Lattig
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

4.  Markers for the central serotonin system correlate to verbal ability and paralinguistic social voice processing in autism spectrum disorder.

Authors:  Yuko Yoshimura; Mitsuru Kikuchi; Daisuke N Saito; Tetsu Hirosawa; Tetsuya Takahashi; Toshio Munesue; Hirotaka Kosaka; Nobushige Naito; Yasuomi Ouchi; Yoshio Minabe
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

5.  Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors.

Authors:  Kenneth Blum; Marjorie C Gondré-Lewis; David Baron; Panayotis K Thanos; Eric R Braverman; Jennifer Neary; Igor Elman; Rajendra D Badgaiyan
Journal:  Front Psychiatry       Date:  2018-11-27       Impact factor: 4.157

6.  A molecular biomarker for prediction of clinical outcome in children with ASD, constipation, and intestinal inflammation.

Authors:  Stephen J Walker; Carl D Langefeld; Kip Zimmerman; Marshall Z Schwartz; Arthur Krigsman
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

Review 7.  Genetic Causes and Modifiers of Autism Spectrum Disorder.

Authors:  Lauren Rylaarsdam; Alicia Guemez-Gamboa
Journal:  Front Cell Neurosci       Date:  2019-08-20       Impact factor: 5.505

8.  Tackling Missing Heritability by Use of an Optimum Curve: A Systematic Review and Meta-Analysis.

Authors:  Anneke Wegener Sleeswijk; Reinout Heijungs; Sarah Durston
Journal:  Int J Mol Sci       Date:  2019-10-15       Impact factor: 5.923

9.  Organic Cation Transporters in Psychiatric Disorders.

Authors:  Lynette C Daws
Journal:  Handb Exp Pharmacol       Date:  2021

Review 10.  Role of the Serotonin Receptor 7 in Brain Plasticity: From Development to Disease.

Authors:  Marianna Crispino; Floriana Volpicelli; Carla Perrone-Capano
Journal:  Int J Mol Sci       Date:  2020-01-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.